Literature DB >> 2899647

Dopamine autoreceptor agonists as potential antipsychotics. 1. (Aminoalkoxy)anilines.

J C Jaen1, L D Wise, T G Heffner, T A Pugsley, L T Meltzer.   

Abstract

The synthesis and pharmacological properties of a novel type of [(arylpiperazinyl)alkoxy]anilines with dopaminergic properties are described. One of these compounds, 3-[3-(4-phenyl-1-piperazinyl)propoxy]benzenamine (4c), has been identified as a selective dopamine (DA) autoreceptor agonist in tests that include [3H]haloperidol binding, inhibition of striatal DA synthesis, inhibition of DA neuronal firing, inhibition of spontaneous locomotor activity, and reversal of reserpine-induced depression in rats. In addition, 4c possesses good oral activity in the Sidman conditioned avoidance test in squirrel monkeys, which is indicative of antipsychotic activity. In a primate model, 4c was found to lack the liability for extrapyramidal side effects usually associated with antipsychotic drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899647     DOI: 10.1021/jm00403a022

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Synthesis and cytotoxic activity evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.

Authors:  Hong Chen; Xue Liang; Fang Xu; Bingbing Xu; Xuelan He; Biyun Huang; Mu Yuan
Journal:  Molecules       Date:  2014-08-12       Impact factor: 4.411

2.  Methyl 4-(4-fluoro-anilino)-1,2,6-tris-(4-fluoro-phen-yl)-1,2,5,6-tetra-hydro-pyri-dine-3-carboxyl-ate.

Authors:  Sumati Anthal; Goutam Brahmachari; Suvankar Das; Rajni Kant; Vivek K Gupta
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-02-09

3.  Ethyl 4-anilino-2,6-bis-(4-fluoro-phen-yl)-1-phenyl-1,2,5,6-tetra-hydro-pyridine-3-carboxyl-ate.

Authors:  Sumati Anthal; Goutam Brahmachari; Suvankar Das; Rajni Kant; Vivek K Gupta
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.